Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Am J Obstet Gynecol ; 212(2): 163-6.e1, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25068558

ABSTRACT

Obstetricians-gynecologists can protect the reproductive health of women, men, and their offspring from environmental hazards through preconception and prenatal counseling and encouraging patients to take actions to reduce environmental exposures. Although obstetricians-gynecologists are well positioned to prevent hazardous exposures, education on environmental health in medical education is limited. The Mid-Atlantic Center for Children's Health and the Environment and the Department of Obstetrics and Gynecology of George Washington University convened a meeting to begin integration of environmental health topics into medical education for obstetricians-gynecologists. Several avenues were identified to incorporate environmental health topics into medical education including continuing education requirements, inclusion of environmental health questions on board certification examinations and the creation of a curriculum on environmental health specific to obstetrics-gynecology.


Subject(s)
Environmental Health/education , Gynecology/education , Obstetrics/education , Curriculum , Education, Medical, Continuing/methods , Education, Medical, Graduate/methods , Education, Medical, Undergraduate/methods , Humans
2.
J Reprod Med ; 51(9): 719-21, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17039702

ABSTRACT

BACKGROUND: Few cases of pregnancy following the Mitrofanoff procedure (continent appendicovesicostomy) have been reported, but in those cases there was an increased rate of cesarean delivery with no long-term consequences to renal function or to the urinary diversion. CASE: A 15-year-old primagravida with a prior nephrectomy for a dysplastic kidney and prior continent appendicovesicostomy for urinary retention due to spina bifida occulta and neurogenic bladder had a pregnancy complicated by preterm premature rupture of membranes, preterm labor, breech presentation and cesarean delivery with the assistance of a urologist. The patient had a minimal decline in renal function, and she and the infant did well. CONCLUSION: Cesarean delivery should be reserved for obstetric indications. Surgical assistance by a urologist at the time of cesarean delivery may be helpful.


Subject(s)
Breech Presentation/surgery , Cesarean Section , Fetal Membranes, Premature Rupture/surgery , Urinary Reservoirs, Continent , Adolescent , Female , Humans , Hydronephrosis/physiopathology , Infant, Newborn , Kidney/physiopathology , Nephrectomy , Pregnancy , Urinary Diversion
3.
J Reprod Med ; 51(9): 725-8, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17039704

ABSTRACT

BACKGROUND: Arrhythmogenic right ventricular dysplasia (ARVD) is characterized by progressive fibrous or fibrofatty tissue replacement of the right ventricular myocardium. Interspersed adipocytes and fibrous tissue may provide foci for arrhythmias. The clinical spectrum of ARVD may include asymptomatic premature ventricular complexes to ventricular tachycardia and sudden death. There is currently little information about ARVD in pregnancy. CASE: A 29-year-old primigravida, diagnosed with ARVD 1 year prior to pregnancy, underwent a full-term, uncomplicated pregnancy and delivery while maintained on acebutolol and an implanted cardioverter defibrillator. Her infant was born without an apparent cardiac anomaly or heart rate abnormality. CONCLUSION: Successful management of pregnancy complicated by ARVD can be accomplished with an implanted cardioverter defibrillator and an antiarrhythmic agent. Such patients should be managed with close monitoring during pregnancy for signs and symptoms of arrhythmia and preventive obstetric care appropriate to their clinical profile to optimize normal deliveries.


Subject(s)
Acebutolol/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Arrhythmogenic Right Ventricular Dysplasia/therapy , Defibrillators, Implantable , Pregnancy Complications, Cardiovascular/therapy , Adult , Combined Modality Therapy , Female , Humans , Infant, Newborn , Pregnancy , Pregnancy Outcome
4.
J Reprod Med ; 51(5): 431-4, 2006 May.
Article in English | MEDLINE | ID: mdl-16779993

ABSTRACT

BACKGROUND: Sacrococcygeal teratoma, the most common congenital neoplasm of the newborn, associated with fetal hydrops and high morbidity and mortality related to the secondary effects of the tumor mass, is of unknown etiology. Prompt diagnosis and early treatment have proven to be effective. CASE: A 24-year-old woman, gravida 3, para 2, at 385/7 weeks' gestation, with a pregnancy complicated by HIV diagnosed during pregnancy, seizure disorder and tobacco use, presented with premature rupture of membranes. Ultrasound examination at 17 weeks' gestation showed normal fetal anatomy. Cesarean delivery was complicated by difficulty delivering a live infant with a large sacral mass. Successful surgical excision of a 650-g mass and stabilization of the infant occurred in the neonatal period. CONCLUSION: This is the first case report to describe a rapidly growing sacrococcygeal teratoma in a neonate from a pregnancy complicated by HIV. Ultrasound in the first and second trimesters identified no fetal abnormalities of the spine. Further research concerning sacrococcygeal teratoma and HIV in pregnancy is necessary for prompt and early diagnosis and treatment of antepartum and peripartum complications.


Subject(s)
HIV Infections/drug therapy , Pregnancy Complications, Infectious/drug therapy , Sacrococcygeal Region/surgery , Teratoma/surgery , Adult , Cesarean Section , Female , Fetal Diseases/etiology , HIV Seropositivity , Humans , Infant, Newborn , Laparoscopy , Pregnancy , Seizures/drug therapy , Seizures/prevention & control , Smoking
5.
Obstet Gynecol ; 107(2 Pt 2): 514-6, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16449169

ABSTRACT

BACKGROUND: Few cases of pregnancy in women with systemic mastocytosis have been reported. The effects of this disease on pregnancy have not been well documented, nor have the benefits of doula services for labor been reported for mastocytosis. CASE: A 35-year-old woman with indolent systemic mastocytosis sought preconception counseling regarding the effects of her disease on pregnancy and the effects of drugs and anesthesia on her disease. She then had an uncomplicated pregnancy and delivery, with multidisciplinary coordination and assistance by doulas to reduce the need for medication in labor. CONCLUSION: Mastocytosis patients can achieve normal pregnancy outcomes. Predelivery planning can help prepare staff and patients for complications. Doulas can assist with labor preparation and delivery using nonmedical approaches to relief of pain and anxiety.


Subject(s)
Caregivers , Mastocytosis, Systemic/therapy , Pregnancy Complications/therapy , Adult , Female , Humans , Pregnancy , Prenatal Care
6.
Am J Obstet Gynecol ; 193(5): 1794-7, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16260236

ABSTRACT

OBJECTIVE: This study was undertaken to develop, implement, and evaluate a genetics curriculum for obstetrician-gynecologist residents. STUDY DESIGN: We prospectively evaluated the effect of a genetics curriculum on obstetrician-gynecologist residents' knowledge and skills. Residents completed a needs assessment and pretest. Educational intervention included 2 3-hour didactic sessions with 1 hour of lecture followed by case discussion and 1 3-hour session of experiential learning using standardized patients who evaluated residents' knowledge and skills in taking family history, drawing genetic pedigrees, and counseling patients. Posttest scores were compared with pretest scores. RESULTS: Needs assessment was completed by all 40 obstetrics and gynecology residents and identified limited and variable genetics education in medical school. Twenty-eight of 40 residents attended the entire educational intervention and completed the pretest and posttest, and 25 of 28 showed improved test scores. Residents stated that they were more confident in their ability to take a family history, record a 3-generation pedigree, and counsel patients about genetic conditions after completion of the genetics curriculum. CONCLUSION: This multifaceted genetics curriculum improved residents' knowledge of genetics as well as their confidence in applying genetic concepts as assessed by the pretest and posttest and by their comments in the debrief session.


Subject(s)
Clinical Competence , Curriculum , Genetic Counseling , Genetics/education , Gynecology/education , Internship and Residency , Obstetrics/education , Program Evaluation , Prospective Studies
7.
J Reprod Med ; 50(5): 370-2, 2005 May.
Article in English | MEDLINE | ID: mdl-15971488

ABSTRACT

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD), an autosomal dominant genetic disorder with a reported prevalence of 1 in 1,000, may be associated with hypertensive disease in pregnancy. The evaluation of a pregnant woman with an adult-onset genetic disorder is complex and involves counseling about inheritance, prenatal diagnosis and management of the current pregnancy. CASE: A 33-year-old woman presented for obstetric care with a history of hypertension and ADPKD for 6 years. The patient had secondary infertility, which was treated by in vitro fertilization. The case was complicated by twin gestation and superimposed severe preeclampsia, leading to preterm cesarean delivery at 26 weeks' estimated gestational age. CONCLUSION: Because of the heritable nature of ADPKD and the long-term risk of end-stage renal disease requiring dialysis and/or renal transplantation, the evaluation and counseling of women with ADPKD who are pregnant or considering pregnancy should include a discussion of the modes of inheritance, natural history, available prenatal diagnostic options, and pregnancy risks and management options. Specific counseling issues in this case include the genetic concepts of variable expression and penetrance and the medical management of chronic hypertension and preeclampsia.


Subject(s)
Polycystic Kidney, Autosomal Dominant/complications , Pre-Eclampsia/complications , Pre-Eclampsia/etiology , Pregnancy Complications , Twins , Adult , Age of Onset , Cesarean Section , Female , Fertilization in Vitro , Genetic Counseling , Humans , Pregnancy , Pregnancy Outcome , Premature Birth , Risk Factors
8.
J Reprod Med ; 50(2): 135-7, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15755051

ABSTRACT

BACKGROUND: Anemia in pregnancy is seen often because of iron deficiency and the "physiologic dilution" that occurs in the third trimester. Other causes include genetic conditions, such as sickle cell anemia and thalassemias. In cases not responding to iron therapy, patients occasionally require a blood transfusion to restore adequate circulating red blood cell mass. In patients belonging to the Jehovah's Witness sect, transfusion of blood products is not allowed, and treatment of anemia in pregnancy may require use of erythropoietin. CASE: A 26-year-old, African American woman belonging to the Jehovah's Witness sect presented with anemia associated with beta-thalassemia. Iron therapy and prenatal vitamins did not correct the anemia, and the patient became symptomatic, with fatigue and shortness of breath when walking. Therapy with synthetic erythropoietin corrected the anemia, and the patient had an otherwise-uncomplicated pregnancy and delivery. CONCLUSION: Synthetic erythropoietin has been used successfully in patients with renal failure and anemia. In pregnancy associated with renal failure and anemia, synthetic erythropoietin has been shown to be safe except for rare cases of hypertension. We treated anemia caused by beta-thalassemia in pregnancy with synthetic erythropoietin to avoid a transfusion in a Jehovah's Witness.


Subject(s)
Anemia, Iron-Deficiency/drug therapy , Erythropoietin/therapeutic use , Jehovah's Witnesses , Pregnancy Complications, Hematologic/diagnosis , Pregnancy Complications, Hematologic/drug therapy , Pregnancy Outcome , beta-Thalassemia/drug therapy , Adult , Anemia, Iron-Deficiency/diagnosis , Female , Follow-Up Studies , Gestational Age , Humans , Pregnancy , Risk Assessment , Treatment Outcome , beta-Thalassemia/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...